ZEMBRACE SYMTOUCH: payments to doctors
Payments that named ZEMBRACE SYMTOUCH as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $686K
- Providers
- 6,736
- Transactions
- 26,092
- Average per transaction
- $26
The per-transaction average — $26 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,736 providers the average total is $102, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Upsher-smith Laboratories LLC | $420,937 | 61.3% |
| Promius Pharma LLC | $125,181 | 18.2% |
| Tonix Medicines, Inc. | $99,050 | 14.4% |
| Tonix Pharmaceuticals, Inc. | $41,223 | 6.0% |